Chronic kidney disease (CKD) has long remained at the margins of the evidence base for the cardiovascular benefits of blood-pressure lowering. The absolute risk of cardiovascular events in people with ...

Longitudinal monitoring of the CKD-REIN cohort reveals that twothirds of patients with renal insufficiency have a stable haemoglobin trajectory and a low associated risk of cardiorenal complications ...

Stage 1 CKD often doesn't cause noticeable symptoms but requires measures to preserve kidney function. Managing high blood ...

Source: Getty Images Addressing anemia in CKD requires a proactive, multifaceted approach, incorporating both conventional and nutritional strategies. Early recognition and intervention are essential ...

Investigators studied response to standard chronic kidney disease (CKD) therapies among real-world patients with monogenic forms of glomerular disease.

"Inclisiran, administered twice-yearly (after initial and 3-month doses) with maximum-tolerated statins or other oral lipid-lowering therapies, provide sustained and effective LDL cholesterol lowering ...

Patients with elevated atherosclerotic CVD and kidney failure risks may never have received a nephrology referral, according ...

Discover the rising prevalence of chronic kidney disease in Singapore and the nation's efforts to manage this growing health ...

Anemia and other contributing factors are common causes of fatigue in chronic kidney disease (CKD). Healthy lifestyle habits and taking steps to meet your nutritional needs can help. If you have ...